Qing Luo

575 total citations
27 papers, 435 citations indexed

About

Qing Luo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qing Luo has authored 27 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Qing Luo's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (4 papers) and Ubiquitin and proteasome pathways (4 papers). Qing Luo is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (4 papers) and Ubiquitin and proteasome pathways (4 papers). Qing Luo collaborates with scholars based in China and Japan. Qing Luo's co-authors include Changzhi Huang, Mei Zhao, Jinbo Liu, Xinghua Yuan, Jialing Zhong, Jiahong Zhou, Yiming Ma, Jia Wang, Shengkai Huang and Wen Xia and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Cancer and Gene.

In The Last Decade

Qing Luo

25 papers receiving 430 citations

Peers

Qing Luo
Felipe Were Spain
Т. Г. Рукша Russia
Lily K. Cheng Hong Kong
Christian Molina‐Aguilar Mexico
Jungmi Ahn United States
Suzanne B.R. Jacobs United States
Ashley Cass United States
Takahiro Itoshima Japan
Shigeru Sugaya Japan
Nadya Al‐Yacoub Saudi Arabia
Felipe Were Spain
Qing Luo
Citations per year, relative to Qing Luo Qing Luo (= 1×) peers Felipe Were

Countries citing papers authored by Qing Luo

Since Specialization
Citations

This map shows the geographic impact of Qing Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Luo more than expected).

Fields of papers citing papers by Qing Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Luo. The network helps show where Qing Luo may publish in the future.

Co-authorship network of co-authors of Qing Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Luo. A scholar is included among the top collaborators of Qing Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Luo. Qing Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luo, Qing, Yan Wang, & Xiaoyun Zhang. (2025). Conversion to laparotomy during laparoscopic hysterectomy: a meta-analysis of prevalence and key risk factors. Frontiers in Surgery. 12. 1522022–1522022.
3.
4.
Wu, Xiuping, et al.. (2023). A cuproptosis-associated long non-coding RNA signature for the prognosis and immunotherapy of lung squamous cell carcinoma. SHILAP Revista de lepidopterología. 23(4). 624–633. 6 indexed citations
5.
Zhang, Mi, Xuexue Liu, Qing Luo, et al.. (2023). Single-cell transcriptomics provide insight into metastasis-related subsets of breast cancer. Breast Cancer Research. 25(1). 126–126. 7 indexed citations
6.
Wang, Kang, et al.. (2022). LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p/MAPK1 axis. Aging. 15(8). 2877–2890. 4 indexed citations
7.
Luo, Qing, Wen Xia, Jiahong Zhou, et al.. (2021). A novel compound heterozygous mutation of the MTO1 gene associated with complex oxidative phosphorylation deficiency type 10. Clinica Chimica Acta. 523. 172–177. 1 indexed citations
8.
Li, Xiaomei, Ni Jiang, Dongchen Shi, et al.. (2021). Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer. Cancer Management and Research. Volume 13. 1189–1204. 16 indexed citations
9.
Zhong, Min, et al.. (2020). Identification of Candidate Genes Associated with Charcot‐Marie‐Tooth Disease by Network and Pathway Analysis. BioMed Research International. 2020(1). 1353516–1353516. 4 indexed citations
10.
Wang, Junqi, et al.. (2020). TBRG4 silencing promotes progression of squamous cell carcinoma via regulation of CAV-1 expression and ROS formation. Cellular and Molecular Biology. 66(2). 157–164. 10 indexed citations
11.
Lu, Lingyun, Zhehao Dai, Qing Luo, & Guohua Lv. (2017). The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma. Molecular Medicine Reports. 17(1). 1947–1953. 14 indexed citations
12.
Huang, Shengkai, Jia Wang, Jia Li, et al.. (2016). Serum microRNA expression profile as a diagnostic panel for gastric cancer. Japanese Journal of Clinical Oncology. 46(9). 811–818. 23 indexed citations
13.
Peng, Hua, Jia Wang, Jia Li, et al.. (2016). A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer. Life Sciences. 151. 235–242. 58 indexed citations
14.
Xiao, Xiong, et al.. (2015). Characterization of HSP70 and its expression in tissue: correlation with physiological and immune indices in goose (Anser cygnoides) serum. Genetics and Molecular Research. 14(4). 12288–12298. 7 indexed citations
15.
Gu, Yuyu, Mei Yang, Mei Zhao, et al.. (2015). The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways. Tumor Biology. 36(11). 8379–8387. 47 indexed citations
16.
Feng, Chuan Liang, et al.. (2015). [Effect of Conditioned Medium from Endothelial Cells on Cancer Stem Cell Phenotype of Hepatoma Cells].. PubMed. 32(5). 1061–6. 3 indexed citations
17.
18.
Zhong, Jialing, Mei Zhao, Qing Luo, et al.. (2012). CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway. Molecular and Cellular Biochemistry. 372(1-2). 1–8. 31 indexed citations
19.
Zhong, Jialing, Mei Zhao, Yiming Ma, et al.. (2012). UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity. International Journal of Molecular Medicine. 30(2). 430–436. 62 indexed citations
20.
Zhao, Mei, Qing Luo, Yiming Ma, et al.. (2009). Overexpression of PIP5KL1 suppresses cell proliferation and migration in human gastric cancer cells. Molecular Biology Reports. 37(5). 2189–2198. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felipe Were Breakdown of academic impact, for papers by Т. Г. Рукша Breakdown of academic impact, for papers by Lily K. Cheng Breakdown of academic impact, for papers by Christian Molina‐Aguilar Breakdown of academic impact, for papers by Jungmi Ahn Breakdown of academic impact, for papers by Suzanne B.R. Jacobs Breakdown of academic impact, for papers by Ashley Cass Breakdown of academic impact, for papers by Takahiro Itoshima Breakdown of academic impact, for papers by Shigeru Sugaya Breakdown of academic impact, for papers by Nadya Al‐Yacoub
Rankless by CCL
2026